Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 1
1976 2
1979 1
1980 1
1981 2
1983 3
1984 3
1985 5
1986 2
1987 3
1988 3
1989 2
1990 1
1991 1
1992 3
1993 2
1994 5
1995 7
1996 5
1997 3
1998 1
1999 5
2000 5
2001 8
2002 4
2003 4
2004 2
2005 4
2006 5
2007 1
2008 5
2009 2
2010 7
2011 5
2012 2
2013 5
2014 4
2016 1
2017 3
2018 2
2019 1
2020 2
2021 3
2022 1
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Evolution of Neuroendocrine Tumor Therapy.
O'Dorisio TM, Harris AG, O'Dorisio MS. O'Dorisio TM, et al. Among authors: o dorisio ms. Surg Oncol Clin N Am. 2020 Apr;29(2):145-163. doi: 10.1016/j.soc.2019.11.002. Surg Oncol Clin N Am. 2020. PMID: 32151353 Free PMC article. Review.
The University of Iowa Neuroendocrine Tumor Clinic.
Howe JR, Menda Y, Chandrasekharan C, Bellizzi AM, Quelle DE, O'Dorisio MS, Dillon JS. Howe JR, et al. Among authors: o dorisio ms. Endocr Pract. 2025 Jan;31(1):4-18. doi: 10.1016/j.eprac.2024.09.018. Epub 2024 Sep 28. Endocr Pract. 2025. PMID: 39349242
Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth.
Johnson SS, Liu D, Ewald JT, Robles-Planells C, Pulliam C, Christensen KA, Bayanbold K, Wels BR, Solst SR, O'Dorisio MS, Menda Y, Spitz DR, Fath MA. Johnson SS, et al. Among authors: o dorisio ms. Cancer Biol Ther. 2024 Dec 31;25(1):2382524. doi: 10.1080/15384047.2024.2382524. Epub 2024 Jul 25. Cancer Biol Ther. 2024. PMID: 39054566 Free PMC article.
Pancreastatin predicts survival in neuroendocrine tumors.
Sherman SK, Maxwell JE, O'Dorisio MS, O'Dorisio TM, Howe JR. Sherman SK, et al. Among authors: o dorisio ms. Ann Surg Oncol. 2014 Sep;21(9):2971-80. doi: 10.1245/s10434-014-3728-0. Epub 2014 Apr 22. Ann Surg Oncol. 2014. PMID: 24752611 Free PMC article. Clinical Trial.
90Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide Therapy.
Menda Y, Madsen MT, O'Dorisio TM, Sunderland JJ, Watkins GL, Dillon JS, Mott SL, Schultz MK, Zamba GKD, Bushnell DL, O'Dorisio MS. Menda Y, et al. Among authors: o dorisio ms. J Nucl Med. 2018 Nov;59(11):1692-1698. doi: 10.2967/jnumed.117.202903. Epub 2018 Mar 9. J Nucl Med. 2018. PMID: 29523629 Free PMC article. Clinical Trial.
142 results